Fundraise / allotmentNotableFiled on BSE ·
HDFC Life Insurance files Q2 FY27 financial results and approves NCD issuance
HDFC Life Insur. · Insurance
What the filing says
- Approved unaudited standalone and consolidated financial results for Q2 and H1 FY27, reviewed by B S R & Co. LLP and KKC & Associates LLP on October 15, 2026
- In-principle approval to raise up to ₹500 crore via issuance of unsecured, rated, listed, subordinated, redeemable, fully-paid, non-cumulative, non-convertible debentures (NCDs)
- Approved establishment of International Financial Services Centre Insurance Office at GIFT IFSC, subject to regulatory and shareholder approvals
Why it's rated notable: amount is ₹500 crore or more
Original filing
Board Meeting Outcome for Outcome Of The Board Meeting - October 15, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies Ltd
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentRane Holdings LtdRane Holdings approves ₹80.85 crore investment in ZF Lifetec Rane JV rights issue
- Fundraise / allotmentCapital Infra TrustCapital Infra Trust submits post-Institutional Placement unit holding pattern
- Fundraise / allotmentCapital Infra TrustCapital Infra Trust raises ₹1,115 crore via QIP for acquiring six HAM road assets
- Fundraise / allotmentPaisalo Digital LtdPaisalo Digital Limited approves Q2 and H1 FY2026-27 unaudited financial results
- Fundraise / allotmentBluestone JewelBlueStone Jewellery to raise up to ₹300 crore via non-convertible debentures
- Fundraise / allotmentAvalon Technologies LtdAvalon Technologies Limited announces Board meeting on Oct 27, 2026 for fund raising
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.